-
1
-
-
17244375049
-
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
-
Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005;434:913-7.
-
(2005)
Nature
, vol.434
, pp. 913-917
-
-
Bryant, H.E.1
Schultz, N.2
Thomas, H.D.3
Parker, K.M.4
Flower, D.5
Lopez, E.6
-
2
-
-
17244373777
-
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
-
Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917-21.
-
(2005)
Nature
, vol.434
, pp. 917-921
-
-
Farmer, H.1
McCabe, N.2
Lord, C.J.3
Tutt, A.N.4
Johnson, D.A.5
Richardson, T.B.6
-
3
-
-
70949086814
-
Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors
-
Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009;52:7170-85.
-
(2009)
J Med Chem
, vol.52
, pp. 7170-7185
-
-
Jones, P.1
Altamura, S.2
Boueres, J.3
Ferrigno, F.4
Fonsi, M.5
Giomini, C.6
-
4
-
-
33748065304
-
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
-
McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 2006;66:8109-15.
-
(2006)
Cancer Res
, vol.66
, pp. 8109-8115
-
-
McCabe, N.1
Turner, N.C.2
Lord, C.J.3
Kluzek, K.4
Bialkowska, A.5
Swift, S.6
-
5
-
-
67650471685
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
-
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009;361:123-34.
-
(2009)
N Engl J Med
, vol.361
, pp. 123-134
-
-
Fong, P.C.1
Boss, D.S.2
Yap, T.A.3
Tutt, A.4
Wu, P.5
Mergui-Roelvink, M.6
-
6
-
-
18344395671
-
Human MRE11 is inactivated in mismatch repair-deficient cancers
-
Giannini G, Ristori E, Cerignoli F, Rinaldi C, Zani M, Viel A, et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep. 2002;3:248-54.
-
(2002)
EMBO Rep
, vol.3
, pp. 248-254
-
-
Giannini, G.1
Ristori, E.2
Cerignoli, F.3
Rinaldi, C.4
Zani, M.5
Viel, A.6
-
7
-
-
0036569940
-
Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability
-
Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002;62:2447-54.
-
(2002)
Cancer Res
, vol.62
, pp. 2447-2454
-
-
Duval, A.1
Hamelin, R.2
-
8
-
-
27744432600
-
Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas
-
Koh KH, Kang HJ, Li LS, Kim NG, You KT, Yang E, et al. Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas. Lab Invest. 2005;85:1130-8.
-
(2005)
Lab Invest
, vol.85
, pp. 1130-1138
-
-
Koh, K.H.1
Kang, H.J.2
Li, L.S.3
Kim, N.G.4
You, K.T.5
Yang, E.6
-
9
-
-
0141731323
-
Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer
-
Fallik D, Borrini F, Boige V, Viguier J, Jacob S, Miquel C, et al. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res. 2003;63:5738-44.
-
(2003)
Cancer Res
, vol.63
, pp. 5738-5744
-
-
Fallik, D.1
Borrini, F.2
Boige, V.3
Viguier, J.4
Jacob, S.5
Miquel, C.6
-
10
-
-
35148887112
-
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability
-
Miquel C, Jacob S, Grandjouan S, Aime A, Viguier J, Sabourin JC, et al. Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability. Oncogene. 2007;26:5919-26.
-
(2007)
Oncogene
, vol.26
, pp. 5919-5926
-
-
Miquel, C.1
Jacob, S.2
Grandjouan, S.3
Aime, A.4
Viguier, J.5
Sabourin, J.C.6
-
11
-
-
33947380240
-
Current Development of Clinical Inhibitors of Poly (ADP-Ribose) Polymerase in Oncology
-
Ratnam K, Low J. Current Development of Clinical Inhibitors of Poly (ADP-Ribose) Polymerase in Oncology. Clin Cancer Res. 2007;13:1383-8.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1383-1388
-
-
Ratnam, K.1
Low, J.2
-
12
-
-
84861322877
-
Topoisomerase I poisoning results in PARP-mediated replication fork reversal
-
Ray CA, Hashimoto Y, Herrador R, Neelsen KJ, Fachinetti D, Bermejo R, et al. Topoisomerase I poisoning results in PARP-mediated replication fork reversal. Nat Struct Mol Biol. 2012;19:417-23.
-
(2012)
Nat Struct Mol Biol
, vol.19
, pp. 417-423
-
-
Ray, C.A.1
Hashimoto, Y.2
Herrador, R.3
Neelsen, K.J.4
Fachinetti, D.5
Bermejo, R.6
-
13
-
-
0033941729
-
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
-
Delaney CA, Wang LZ, Kyle S, White AW, Calvert AH, Curtin NJ, et al. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clin Cancer Res. 2000;6:2860-7.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2860-2867
-
-
Delaney, C.A.1
Wang, L.Z.2
Kyle, S.3
White, A.W.4
Calvert, A.H.5
Curtin, N.J.6
-
14
-
-
28544441999
-
The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks
-
Smith LM, Willmore E, Austin CA, Curtin NJ. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Clin Cancer Res. 2005;11:8449-57.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8449-8457
-
-
Smith, L.M.1
Willmore, E.2
Austin, C.A.3
Curtin, N.J.4
-
15
-
-
84856738573
-
Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes
-
Patel AG, Flatten KS, Schneider PA, Dai NT, McDonald JS, Poirier GG, et al. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes. J Biol Chem. 2012;287:4198-210.
-
(2012)
J Biol Chem
, vol.287
, pp. 4198-4210
-
-
Patel, A.G.1
Flatten, K.S.2
Schneider, P.A.3
Dai, N.T.4
McDonald, J.S.5
Poirier, G.G.6
-
16
-
-
80052238687
-
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas
-
Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, et al. Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. Cancer Res. 2011;71:5626-34.
-
(2011)
Cancer Res
, vol.71
, pp. 5626-5634
-
-
Kummar, S.1
Chen, A.2
Ji, J.3
Zhang, Y.4
Reid, J.M.5
Ames, M.6
-
17
-
-
33845672155
-
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma
-
Tentori L, Leonetti C, Scarsella M, Muzi A, Mazzon E, Vergati M, et al. Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. FASEB J. 2006;20:1709-11.
-
(2006)
FASEB J
, vol.20
, pp. 1709-1711
-
-
Tentori, L.1
Leonetti, C.2
Scarsella, M.3
Muzi, A.4
Mazzon, E.5
Vergati, M.6
-
18
-
-
55949099916
-
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines
-
Vilar E, Scaltriti M, Balmana J, Saura C, Guzman M, Arribas J, et al. Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines. Br J Cancer. 2008;99:1607-12.
-
(2008)
Br J Cancer
, vol.99
, pp. 1607-1612
-
-
Vilar, E.1
Scaltriti, M.2
Balmana, J.3
Saura, C.4
Guzman, M.5
Arribas, J.6
-
19
-
-
64649096900
-
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803
-
Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol. 2009;27:1814-21.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1814-1821
-
-
Bertagnolli, M.M.1
Niedzwiecki, D.2
Compton, C.C.3
Hahn, H.P.4
Hall, M.5
Damas, B.6
-
20
-
-
0030665624
-
Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors
-
Zhou XP, Hoang JM, Cottu P, Thomas G, Hamelin R. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene. 1997;15:1713-8.
-
(1997)
Oncogene
, vol.15
, pp. 1713-1718
-
-
Zhou, X.P.1
Hoang, J.M.2
Cottu, P.3
Thomas, G.4
Hamelin, R.5
-
21
-
-
0031015728
-
BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines
-
Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res. 1997;57:300-3.
-
(1997)
Cancer Res
, vol.57
, pp. 300-303
-
-
Hoang, J.M.1
Cottu, P.H.2
Thuille, B.3
Salmon, R.J.4
Thomas, G.5
Hamelin, R.6
-
22
-
-
13044251809
-
Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells
-
Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci U S A. 1999;96:2316-21.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 2316-2321
-
-
Efstathiou, J.A.1
Liu, D.2
Wheeler, J.M.3
Kim, H.C.4
Beck, N.E.5
Ilyas, M.6
-
23
-
-
0028362325
-
Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation
-
Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet. 1994;6:273-81.
-
(1994)
Nat Genet
, vol.6
, pp. 273-281
-
-
Shibata, D.1
Peinado, M.A.2
Ionov, Y.3
Malkhosyan, S.4
Perucho, M.5
-
24
-
-
0028301255
-
Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability
-
Umar A, Boyer JC, Thomas DC, Nguyen DC, Risinger JI, Boyd J, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem. 1994;269:14367-70.
-
(1994)
J Biol Chem
, vol.269
, pp. 14367-14370
-
-
Umar, A.1
Boyer, J.C.2
Thomas, D.C.3
Nguyen, D.C.4
Risinger, J.I.5
Boyd, J.6
-
25
-
-
0027936057
-
Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation
-
Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 1994;54:4308-12.
-
(1994)
Cancer Res
, vol.54
, pp. 4308-4312
-
-
Koi, M.1
Umar, A.2
Chauhan, D.P.3
Cherian, S.P.4
Carethers, J.M.5
Kunkel, T.A.6
-
27
-
-
10344225054
-
MRE11 expression is impaired in gastric cancer with microsatellite instability
-
Ottini L, Falchetti M, Saieva C, De Marco M, Masala G, Zanna I, et al. MRE11 expression is impaired in gastric cancer with microsatellite instability. Carcinogenesis. 2004;25:2337-43.
-
(2004)
Carcinogenesis
, vol.25
, pp. 2337-2343
-
-
Ottini, L.1
Falchetti, M.2
Saieva, C.3
De Marco, M.4
Masala, G.5
Zanna, I.6
-
28
-
-
79953313615
-
MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers
-
Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V, et al. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Cancer Res. 2011;71:2632-42.
-
(2011)
Cancer Res
, vol.71
, pp. 2632-2642
-
-
Vilar, E.1
Bartnik, C.M.2
Stenzel, S.L.3
Raskin, L.4
Ahn, J.5
Moreno, V.6
-
29
-
-
84880326910
-
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies
-
Gaymes TJ, Mohamedali AM, Patterson M, Matto N, Smith A, Kulasekararaj A, et al. Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies. Haematologica. 2013;98:1397-406.
-
(2013)
Haematologica
, vol.98
, pp. 1397-1406
-
-
Gaymes, T.J.1
Mohamedali, A.M.2
Patterson, M.3
Matto, N.4
Smith, A.5
Kulasekararaj, A.6
-
30
-
-
84880777712
-
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
-
Sandhu SK, Schelman WR, Wilding G, Moreno V, Baird RD, Miranda S, et al. The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. Lancet Oncol. 2013;14:882-92.
-
(2013)
Lancet Oncol
, vol.14
, pp. 882-892
-
-
Sandhu, S.K.1
Schelman, W.R.2
Wilding, G.3
Moreno, V.4
Baird, R.D.5
Miranda, S.6
-
31
-
-
84866071912
-
Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models
-
Clark CC, Weitzel JN, O'Connor TR. Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models. Mol Cancer Ther. 2012;11:1948-58.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 1948-1958
-
-
Clark, C.C.1
Weitzel, J.N.2
O'Connor, T.R.3
-
32
-
-
84874827306
-
A phase I study of chronically dosed, single-agent veliparib (ABT-888) in patients (pts) with either BRCA 1/2-mutated cancer (BRCA+), platinum-refractory ovarian cancer, or basal-like breast cancer (BRCA-wt) [abstract]
-
Huggins-Puhalla SL, Beumer JH, Appleman JL, Tawbi HA-H, Stoller RG, Lin Y, et al. A phase I study of chronically dosed, single-agent veliparib (ABT-888) in patients (pts) with either BRCA 1/2-mutated cancer (BRCA+), platinum-refractory ovarian cancer, or basal-like breast cancer (BRCA-wt) [abstract]. ASCO. 2012;30:s3054.
-
(2012)
ASCO
, vol.30
, pp. s3054
-
-
Huggins-Puhalla, S.L.1
Beumer, J.H.2
Appleman, J.L.3
Tawbi, H.A.-H.4
Stoller, R.G.5
Lin, Y.6
|